Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Malignant Lymphoma

  Free Subscription


1 Am J Hematol
6 Blood
1 BMC Cancer
1 Br J Haematol
3 J Clin Oncol
1 Lab Invest
6 Leuk Lymphoma
1 PLoS One
1 Radiother Oncol

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Hematol

  1. BELETE H, Burns LJ, Shanley R, Nayar M, et al
    Transplantation related toxicity and mortality in older autologous hematopoietic cell transplantation recipients.
    Am J Hematol. 2017;92:E529-E533.
    PubMed     Text format     Abstract available


  2. CARTRON G, Watier H
    Obinutuzumab: what is there to learn from clinical trials?
    Blood. 2017;130:581-589.
    PubMed     Text format     Abstract available

  3. OKONKWO L, Jaffe ES
    Intravascular large cell lymphoma of NK/T-cell type, EBV positive.
    Blood. 2017;130:837.
    PubMed     Text format    

  4. NAM AS, Tam W
    An intrasinusoidal extracavitary variant of primary effusion lymphoma.
    Blood. 2017;130:836.
    PubMed     Text format    

  5. WEIGERT O, Weinstock DM
    The promises and challenges of using gene mutations for patient stratification in follicular lymphoma.
    Blood. 2017 Aug 7. pii: blood-2017-07-737353. doi: 10.1182/blood-2017-07-737353.
    PubMed     Text format     Abstract available

  6. KUO SH, Chen LT, Lin CW, Yeh KH, et al
    Expressions of the CagA protein and CagA-signaling molecules predict Helicobacter pylori dependence of early-stage gastric DLBCL.
    Blood. 2017;129:188-198.
    PubMed     Text format     Abstract available

  7. BUJISIC B, De Gassart A, Tallant R, Demaria O, et al
    Impairment of both IRE1 expression and XBP1 activation is a hallmark of GCB DLBCL and contributes to tumor growth.
    Blood. 2017;129:2420-2428.
    PubMed     Text format     Abstract available

    BMC Cancer

  8. BEN YOUNES K, Body S, Coste E, Viailly PJ, et al
    A lowered 26S proteasome activity correlates with mantle lymphoma cell lines resistance to genotoxic stress.
    BMC Cancer. 2017;17:538.
    PubMed     Text format     Abstract available

    Br J Haematol

  9. ALONSO-ALVAREZ S, Magnano L, Alcoceba M, Andrade-Campos M, et al
    Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group.
    Br J Haematol. 2017 Aug 7. doi: 10.1111/bjh.14831.
    PubMed     Text format     Abstract available

    J Clin Oncol

  10. HERRERA AF, Mei M, Low L, Kim HT, et al
    Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation.
    J Clin Oncol. 2017;35:24-31.
    PubMed     Text format     Abstract available

  11. MOSSE YP, Voss SD, Lim MS, Rolland D, et al
    Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study.
    J Clin Oncol. 2017 Aug 8:JCO2017734830. doi: 10.1200/JCO.2017.73.4830.
    PubMed     Text format     Abstract available

  12. VITOLO U, Trneny M, Belada D, Burke JM, et al
    Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma.
    J Clin Oncol. 2017 Aug 10:JCO2017733402. doi: 10.1200/JCO.2017.73.3402.
    PubMed     Text format     Abstract available

    Lab Invest

  13. JIANG N, Chen C, Gong Q, Shields K, et al
    Flow cytometric sorting coupled with exon capture sequencing identifies somatic mutations in archival lymphoma tissues.
    Lab Invest. 2017 Aug 7. doi: 10.1038/labinvest.2017.
    PubMed     Text format     Abstract available

    Leuk Lymphoma

  14. BUR H, Haapasaari KM, Turpeenniemi-Hujanen T, Kuittinen O, et al
    Low Rap1-interacting factor 1 and sirtuin 6 expression predict poor outcome in radiotherapy-treated Hodgkin lymphoma patients.
    Leuk Lymphoma. 2017 Aug 8:1-11. doi: 10.1080/10428194.2017.1344840.
    PubMed     Text format     Abstract available

  15. HU B, Younes A, Westin JR, Turturro F, et al
    Phase-I and randomized phase-II trial of panobinostat in combination with ICE (ifosfamide, carboplatin, etoposide) in relapsed or refractory classical Hodgkin lymphoma.
    Leuk Lymphoma. 2017 Aug 9:1-8. doi: 10.1080/10428194.2017.1359741.
    PubMed     Text format     Abstract available

  16. RYLAND GL, Jones K, McBean M, Khot A, et al
    Comprehensive genomic characterization dissects the complex biology of a case of synchronous Burkitt lymphoma and myeloid malignancy with shared hematopoietic ancestry.
    Leuk Lymphoma. 2017 Aug 9:1-4. doi: 10.1080/10428194.2017.1361029.
    PubMed     Text format    

  17. Wendtner C-M, and Gregor M. Current perspectives on the role of chemotherapy in chronic lymphocytic leukemia. Leuk Lymphoma. 2017. http://dx.doi.org/10.1080/10428194.2017.1330474.
    Leuk Lymphoma. 2017 Aug 10:1. doi: 10.1080/10428194.2017.1363546.
    PubMed     Text format    

  18. PARIKH A, Gopalakrishnan S, Freise KJ, Verdugo ME, et al
    Exposure-response evaluations of venetoclax efficacy and safety in patients with non-Hodgkin lymphoma.
    Leuk Lymphoma. 2017 Aug 10:1-9. doi: 10.1080/10428194.2017.1361024.
    PubMed     Text format     Abstract available

  19. GUIDOT DM, Switchenko JM, Nastoupil LJ, Koff JL, et al
    Surveillance imaging in mantle cell lymphoma in first remission lacks clinical utility.
    Leuk Lymphoma. 2017 Aug 10:1-8. doi: 10.1080/10428194.2017.1361032.
    PubMed     Text format     Abstract available

    PLoS One

  20. MCKENZIE LM, Allshouse WB, Byers TE, Bedrick EJ, et al
    Childhood hematologic cancer and residential proximity to oil and gas development.
    PLoS One. 2017;12:e0170423.
    PubMed     Text format     Abstract available

    Radiother Oncol

  21. BATES JE, Dhakal S, Mazloom A, Casulo C, et al
    Benefit from the inclusion of radiation therapy in the treatment of patients with stage III classical Hodgkin lymphoma: A propensity matched analysis of the Surveillance, Epidemiology, and End Results database.
    Radiother Oncol. 2017 Aug 1. pii: S0167-8140(17)32475.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.